To amend title XVIII of the Social Security Act to establish a full risk ACO program.

HR8129, referred to the Committees on Ways and Means and Energy and Commerce, creates a full risk Accountable Care Organization (ACO) program under Medicare. This bill mandates that ACOs take on full financial risk for patient populations, moving away from fee-for-service models. This is a direct expansion of value-based care initiatives, which incentivizes providers to manage costs and improve patient outcomes. The money trail for this legislation flows directly to entities capable of managing large-scale population health and financial risk. Health insurance companies, already adept at risk management and provider network administration, are positioned to expand their ACO offerings. Healthcare technology companies providing data analytics, care coordination platforms, and risk stratification tools will see increased demand. The mechanism is through new Medicare reimbursement structures that reward ACOs for efficiency and quality, with a portion of savings shared with the ACOs themselves. Historically, the Affordable Care Act (ACA) of 2010 introduced and expanded ACO models, albeit with varying levels of risk. Following the ACA's implementation, companies like UnitedHealth Group ($UNH) and Humana ($HUM) saw increased enrollment in their Medicare Advantage plans, which often incorporate similar value-based principles. While not a direct comparison to a full-risk mandate, the trend towards value-based care has consistently favored integrated healthcare providers and insurers. For example, after CMS announced the ACO REACH model in February 2022, which increased risk-sharing, companies like Privia Health Group ($PRVA) and Aledade (private) saw increased interest and investment, reflecting market anticipation of growth in advanced ACO models. Specific winners include large health insurers such as UnitedHealth Group ($UNH), Humana ($HUM), CVS Health ($CVS) (through Aetna), Centene Corporation ($CNC), and Molina Healthcare ($MOH), as they possess the infrastructure and capital to manage full financial risk for large patient populations. Healthcare technology companies like Progyny ($PGNY) (for specialized care management) and Accolade ($ACCO) (for care navigation and data analytics) also stand to gain from increased demand for their services within these new ACO structures. The bill is in its initial committee referral stage; the next step is committee consideration and potential markup, which could occur within the next 6-12 months.